Joakim Isendahl1, Christian G Giske2, Ulf Hammar3, Pär Sparen4, Karin Tegmark Wisell5, Anders Ternhag1,6, Pontus Nauclér1,6. 1. Department of Medicine Solna, Unit for Infectious Diseases, Karolinska University Hospital. 2. Department of Laboratory Medicine, Laboratory Building L2:02, Karolinska University Hospital Laboratory. 3. Institute of Environmental Medicine, C6, Biostatistics. 4. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm. 5. Public Health Agency of Solna. 6. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Abstract
Background: Little is known of the long-term risks of bloodstream infection (BSI) with extended spectrum β-lactamase-producing Enterobacteriaceae (EPE) in previously-colonized individuals. We investigated EPE-BSI risks and associated risk factors during 6 years following EPE colonization. Methods: We performed a population-based cohort study in Sweden using national health registers. Subjects were followed from their first EPE finding in feces (n = 5513) or urine (n = 17189). The effects of co-morbidity, sociodemography, and outpatient antibiotic dispensation on EPE-BSI risks were assessed. The EPE-BSI risks were compared to those of 45161 matched population-based reference subjects. Results: The cumulative 6-year EPE-BSI incidences were 3.8%, 1.6%, and 0.02% in the urine, feces, and reference cohorts, respectively. The incidences decreased exponentially during the first 6-12 months. Among EPE-exposed subjects, urological disorders were associated with the highest adjusted cause-specific hazard ratio (aCSHR) for subsequent EPE-BSIs (3.40, 95% confidence interval 2.47-4.69). The aCSHRs were between 1.62-2.20 for male sex, immunosuppression, diabetes, malignancy, lung disease, baseline urine source, and Klebsiella pneumoniae, compared to the Escherichia coli baseline sample. Antibiotics with selective activity against gram-negative bacilli-but mostly not EPE (trimethoprim-sulfamethoxazole, fluoroquinolones, oral cephalosporins, and penicillins with extended spectrums)-and pivmecillinam were associated with doubled EPE BSI risk during the 3 months after antibiotic dispensation in EPE-colonized subjects. Conclusions: EPE in urine or feces is a substantial risk factor for subsequent EPE-BSIs, but the risk declines rapidly during the first year after detection. In EPE-colonized individuals, specific risk factors can be used to identify subgroups for targeted interventions, such as eradication therapy.
Background: Little is known of the long-term risks of bloodstream infection (BSI) with extended spectrum β-lactamase-producing Enterobacteriaceae (EPE) in previously-colonized individuals. We investigated EPE-BSI risks and associated risk factors during 6 years following EPE colonization. Methods: We performed a population-based cohort study in Sweden using national health registers. Subjects were followed from their first EPE finding in feces (n = 5513) or urine (n = 17189). The effects of co-morbidity, sociodemography, and outpatient antibiotic dispensation on EPE-BSI risks were assessed. The EPE-BSI risks were compared to those of 45161 matched population-based reference subjects. Results: The cumulative 6-year EPE-BSI incidences were 3.8%, 1.6%, and 0.02% in the urine, feces, and reference cohorts, respectively. The incidences decreased exponentially during the first 6-12 months. Among EPE-exposed subjects, urological disorders were associated with the highest adjusted cause-specific hazard ratio (aCSHR) for subsequent EPE-BSIs (3.40, 95% confidence interval 2.47-4.69). The aCSHRs were between 1.62-2.20 for male sex, immunosuppression, diabetes, malignancy, lung disease, baseline urine source, and Klebsiella pneumoniae, compared to the Escherichia coli baseline sample. Antibiotics with selective activity against gram-negative bacilli-but mostly not EPE (trimethoprim-sulfamethoxazole, fluoroquinolones, oral cephalosporins, and penicillins with extended spectrums)-and pivmecillinam were associated with doubled EPE BSI risk during the 3 months after antibiotic dispensation in EPE-colonized subjects. Conclusions: EPE in urine or feces is a substantial risk factor for subsequent EPE-BSIs, but the risk declines rapidly during the first year after detection. In EPE-colonized individuals, specific risk factors can be used to identify subgroups for targeted interventions, such as eradication therapy.
Authors: T D Verschuuren; D van Hout; S Arredondo-Alonso; A C Fluit; E A Reuland; J Top; A C Schürch; T Bosch; M J M Bonten; J A J W Kluytmans; R J L Willems Journal: J Antimicrob Chemother Date: 2021-03-12 Impact factor: 5.790
Authors: Roel P J Willems; Karin van Dijk; Cindy M Dierikx; Jos W R Twisk; Fiona R M van der Klis; Sabine C de Greeff; Christina M J E Vandenbroucke-Grauls Journal: J Antimicrob Chemother Date: 2021-12-24 Impact factor: 5.790
Authors: Mohammed Badrul Amin; Kazi Injamamul Hoque; Subarna Roy; Sumita Rani Saha; Md Rayhanul Islam; Timothy R Julian; Mohammad Aminul Islam Journal: Front Microbiol Date: 2022-03-31 Impact factor: 5.640
Authors: Sameer S Kadri; Yi Ling Lai; Sarah Warner; Jeffrey R Strich; Ahmed Babiker; Emily E Ricotta; Cumhur Y Demirkale; John P Dekker; Tara N Palmore; Chanu Rhee; Michael Klompas; David C Hooper; John H Powers; Arjun Srinivasan; Robert L Danner; Jennifer Adjemian Journal: Lancet Infect Dis Date: 2020-09-08 Impact factor: 25.071